Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
119.65
-0.14 (-0.12%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Haemonetics Market Cap
Haemonetics has a market cap or net worth of $5.44 billion as of October 30, 2026. It is the 3,348th most valuable company in the world and the 1,095th biggest in the United States. Its market cap has increased by 128.55% in one year.
Market Cap
5.44B
Enterprise Value
6.39B
1-Year Change
128.55%
Global Rank
Country Rank
#1,095 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Haemonetics's market cap has increased from $605.00M to $5.44B, an increase of 799.79%. That is a compound annual growth rate of 8.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 5.44B | 45.10% |
| Dec 31, 2025 | 3.75B | -4.33% |
| Dec 31, 2024 | 3.92B | -9.62% |
| Dec 29, 2023 | 4.34B | 9.01% |
| Dec 30, 2022 | 3.98B | 46.84% |
| Dec 31, 2021 | 2.71B | -55.05% |
| Dec 31, 2020 | 6.03B | 3.54% |
| Dec 31, 2019 | 5.82B | 12.62% |
| Dec 31, 2018 | 5.17B | 68.56% |
| Dec 29, 2017 | 3.07B | 47.73% |
| Dec 30, 2016 | 2.08B | 26.98% |
| Dec 31, 2015 | 1.64B | -14.87% |
| Dec 31, 2014 | 1.92B | -11.51% |
| Dec 31, 2013 | 2.17B | 3.06% |
| Dec 31, 2012 | 2.11B | 37.73% |
| Dec 30, 2011 | 1.53B | -2.18% |
| Dec 31, 2010 | 1.56B | 10.69% |
| Dec 31, 2009 | 1.41B | -1.15% |
| Dec 31, 2008 | 1.43B | -10.77% |
| Dec 31, 2007 | 1.60B | 32.14% |
| Dec 29, 2006 | 1.21B | -6.31% |
| Dec 30, 2005 | 1.29B | 40.58% |
| Dec 31, 2004 | 920.10M | 59.08% |
| Dec 31, 2003 | 578.40M | 10.51% |
| Dec 31, 2002 | 523.40M | -41.55% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Globus Medical | 10.48B |
| Insulet | 10.38B |
| Bio-Rad Laboratories | 9.99B |
| Bio-Rad Laboratories | 9.95B |
| 10x Genomics | 9.13B |
| Bruker | 8.70B |
| LivaNova | 4.35B |
| Integer Holdings | 4.30B |